Implicit Decomposition for Write-Efficient Connectivity Algorithms

The future of main memory appears to lie in the direction of new technologies that provide strong capacity-to-performance ratios, but have write operations that are much more expensive than reads in terms of latency, bandwidth, and energy. Motivated by this trend, we propose sequential and parallel algorithms to solve graph connectivity problems using significantly fewer writes than conventional algorithms. Our primary algorithmic tool is the construction of an $o(n)$-sized "implicit decomposition" of a bounded-degree graph $G$ on $n$ nodes, which combined with read-only access to $G$ enables fast answers to connectivity and biconnectivity queries on $G$. The construction breaks the linear-write "barrier", resulting in costs that are asymptotically lower than conventional algorithms while adding only a modest cost to querying time. For general non-sparse graphs on $m$ edges, we also provide the first $o(m)$ writes and $O(m)$ operations parallel algorithms for connectivity and biconnectivity. These algorithms provide insight into how applications can efficiently process computations on large graphs in systems with read-write asymmetry

Energy Loss of Leading Hadrons and Direct Photon production in Evolving Quark-Gluon Plasma

We calculate the nuclear modification factor of neutral pions and the photon yield at high p_T in central Au-Au collisions at RHIC (\sqrt{s}=200 GeV) and Pb-Pb collisions at the LHC (\sqrt{s}=5500 GeV). A leading-order accurate treatment of jet energy loss in the medium has been convolved with a physical description of the initial spatial distribution of jets and a (1+1) dimensional expansion. We reproduce the nuclear modification factor of pion R_{AA} at RHIC, assuming an initial temperature T_i=370 MeV and a formation time \tau_i=0.26 fm/c, corresponding to dN/dy=1260. The resulting suppression depends on the particle rapidity density dN/dy but weakly on the initial temperature. The jet energy loss treatment is also included in the calculation of high p_T photons. Photons coming from primordial hard N-N scattering are the dominant contribution at RHIC for p_T > 5 GeV, while at the LHC, the range 8<p_T<14 GeV is dominated by jet-photon conversion in the plasma.Comment: 21 pages, 16 figures. Discussions and references added. New figure includind photon dat

Resting Hormone Alterations and Injuries: Block vs. DUP Weight-Training among D-1 Track and Field Athletes

Daily undulating periodization (DUP), using daily alterations in repetitions, has been advocated as a superior method of resistance training, while traditional forms of programming for periodization (Block) have been questioned. Nineteen Division I track and field athletes were assigned to either a 10-week Block or DUP training group. Year and event were controlled. Over the course of the study, there were four testing sessions, which were used to evaluate a variety of strength characteristics, including maximum isometric strength, rate of force development, and one repetition maximum (1RM). Although, performance trends favored the Block group for strength and rate of force development, no statistical differences were found between the two groups. However, different (p ≤ 0.05) estimated volumes of work (VL) and amounts of improvement per VL were found between groups. Based upon calculated training efficiency scores, these data indicate that a Block training model is more efficient in producing strength gains than a DUP model. Additionally, alterations in testosterone (T), cortisol (C) and the T:C ratio were measured. Although there were no statistically (p ≤ 0.05) different hormone alterations between groups, relationships between training variables and hormone concentrations including the T:C ratio, indicate that Block may be more efficacious in terms of fatigue management

Diversity and morphological characterization of Musa spp. in North Kivu and Ituri provinces, Eastern Democratic Republic of Congo

Eastern Democratic Republic of Congo constitutes an area where the East African Highland bananas (Musa-AAA-EA) and plantains (Musa-AAB) meet. However, Musa diversity in this region has never been characterized nor represented in national or international collections, yet increasing human activities and build-up of pests and diseases, especially Xanthomonas wilt of banana and banana bunchy top disease, could negatively affect this diversity. This study assessed, collected and morphologically characterized on-farm Musa diversity in the North Kivu and Ituri provinces. Musa accessions collected were added to the UCG-Butembo in situ field collection. A total of 90 and 150 farms were assessed, respectively, in the North Kivu and Ituri provinces. High Musa variability was observed in both provinces. Forty-one cultivars (six presumed new) were identified in Ituri Province compared to 38 cultivars (13 presumed new) in North Kivu Province. Nineteen cultivars occurred in both provinces. Beni and Lubero territories in North Kivu and Mambasa territory in Ituri Province had greater Musa diversity, varying between 27 and 38 cultivars, approximately double of the number of cultivars observed in the other territories. Twenty-three of the 34 Musa descriptors contributed more to the discrimination of the cultivars identified across the provinces and were therefore used for grouping the cultivars using principal component analysis (PCA). The Morisita index of similarity between Ituri Province and North Kivu Province territories was less than 0.5, suggesting dissimilarity in diversity between these sites. Six cultivars: ‘Kirisirya’, ‘Pakuma’, ‘Nziravahima’, ‘Vuhindi’, ‘Tundu’ and ‘Kisubi musa’ were reportedly at risk of genetic erosion

Identification of resistance determinants for a promising antileishmanial oxaborole series

Current treatment options for visceral leishmaniasis have several drawbacks, and clinicians are confronted with an increasing number of treatment failures. To overcome this, the Drugs for Neglected Diseases initiative (DNDi) has invested in the development of novel antileishmanial leads, including a very promising class of oxaboroles. The mode of action/resistance of this series to Leishmania is still unknown and may be important for its further development and implementation. Repeated in vivo drug exposure and an in vitro selection procedure on both extracellular promastigote and intracellular amastigote stages were both unable to select for resistance. The use of specific inhibitors for ABC-transporters could not demonstrate the putative involvement of efflux pumps. Selection experiments and inhibitor studies, therefore, suggest that resistance to oxaboroles may not emerge readily in the field. The selection of a genome-wide cosmid library coupled to next-generation sequencing (Cos-seq) was used to identify resistance determinants and putative targets. This resulted in the identification of a highly enriched cosmid, harboring genes of chromosome 2 that confer a subtly increased resistance to the oxaboroles tested. Moderately enriched cosmids encompassing a region of chromosome 34 contained the cleavage and polyadenylation specificity factor (cpsf) gene, encoding the molecular target of several related benzoxaboroles in other organisms

Daily Preventive Zinc Supplementation Decreases Lymphocyte and Eosinophil Concentrations in Rural Laotian Children from Communities with a High Prevalence of Zinc Deficiency: Results of a Randomized Controlled Trial.

BACKGROUND:Zinc deficiency impairs immune function and is common among children in South-East Asia. OBJECTIVES:The effect of zinc supplementation on immune function in young Laotian children was investigated. METHODS:Children (n = 512) aged 6-23 mo received daily preventive zinc tablets (PZ; 7 mg Zn/d), daily multiple micronutrient powder (MNP; 10 mg Zn/d, 6 mg Fe/d, plus 13 other micronutrients), therapeutic dispersible zinc tablets only in association with diarrhea episodes (TZ; 20 mg Zn/d for 10 d after an episode), or daily placebo powder (control). These interventions continued for 9 mo. Cytokine production from whole blood cultures, the concentrations of T-cell populations, and a complete blood count with differential leukocyte count were measured at baseline and endline. Endline means were compared via ANCOVA, controlling for the baseline value of the outcome, child age and sex, district, month of enrollment, and baseline zinc status (below, or above or equal to, the median plasma zinc concentration). RESULTS:T-cell cytokines (IL-2, IFN-γ, IL-13, IL-17), LPS-stimulated cytokines (IL-1β, IL-6, TNF-α, and IL-10), and T-cell concentrations at endline did not differ between intervention groups, nor was there an interaction with baseline zinc status. However, mean ± SE endline lymphocyte concentrations were significantly lower in the PZ than in the control group (5018 ± 158 compared with 5640 ± 160 cells/μL, P = 0.032). Interactions with baseline zinc status were seen for eosinophils (Pixn = 0.0036), basophils (Pixn = 0.023), and monocytes (P = 0.086) but a significant subgroup difference was seen only for eosinophils, where concentrations were significantly lower in the PZ than in the control group among children with baseline plasma zinc concentrations below the overall median (524 ± 44 compared with 600 ± 41 cells/μL, P = 0.012). CONCLUSIONS:Zinc supplementation of rural Laotian children had no effect on cytokines or T-cell concentrations, although zinc supplementation affected lymphocyte and eosinophil concentrations. These cell subsets may be useful as indicators of response to zinc supplementation.This trial was registered at clinicaltrials.gov as NCT02428647

Phase II Open Label Study of Valproic Acid in Spinal Muscular Atrophy

UNLABELLED:Preliminary in vitro and in vivo studies with valproic acid (VPA) in cell lines and patients with spinal muscular atrophy (SMA) demonstrate increased expression of SMN, supporting the possibility of therapeutic benefit. We performed an open label trial of VPA in 42 subjects with SMA to assess safety and explore potential outcome measures to help guide design of future controlled clinical trials. Subjects included 2 SMA type I ages 2-3 years, 29 SMA type II ages 2-14 years and 11 type III ages 2-31 years, recruited from a natural history study. VPA was well-tolerated and without evident hepatotoxicity. Carnitine depletion was frequent and temporally associated with increased weakness in two subjects. Exploratory outcome measures included assessment of gross motor function via the modified Hammersmith Functional Motor Scale (MHFMS), electrophysiologic measures of innervation including maximum ulnar compound muscle action potential (CMAP) amplitudes and motor unit number estimation (MUNE), body composition and bone density via dual-energy X-ray absorptiometry (DEXA), and quantitative blood SMN mRNA levels. Clear decline in motor function occurred in several subjects in association with weight gain; mean fat mass increased without a corresponding increase in lean mass. We observed an increased mean score on the MHFMS scale in 27 subjects with SMA type II (p<or=0.001); however, significant improvement was almost entirely restricted to participants <5 years of age. Full length SMN levels were unchanged and Delta7SMN levels were significantly reduced for 2 of 3 treatment visits. In contrast, bone mineral density (p<or=0.0036) and maximum ulnar CMAP scores (p<or=0.0001) increased significantly. CONCLUSIONS:While VPA appears safe and well-tolerated in this initial pilot trial, these data suggest that weight gain and carnitine depletion are likely to be significant confounding factors in clinical trials. This study highlights potential strengths and limitations of various candidate outcome measures and underscores the need for additional controlled clinical trials with VPA targeting more restricted cohorts of subjects. TRIAL REGISTRATION:ClinicalTrials.gov